CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biota Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biota Holdings Ltd
Notting Hill, U 10 585 Blackburn Rd
Phone: +61 399153700p:+61 399153700 Melbourne, VIC  3168  Australia Fax: +61 399153702f:+61 399153702

This company was Merged or Acquired on 11/8/2012.
This is a Subsidiary, click here for the Parent Company

Business Summary
Biota Holdings Limited is engaged in the drug discovery and clinical development of anti-infectives, suitable for human use and commercialization. The Company licensed zanamivir, which is a neuraminidase inhibitor (influenza antiviral), to GlaxoSmithKline (GSK) and marketed as Relenza. The Company’s research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections. The Company has clinical trials underway with its lead compound for human rhinovirus (HRV) infection in patients with compromised respiration or immune systems. In addition, the Company and Daiichi Sankyo co-own a range of second generation influenza antivirals, of which the lead product lnavir, is approved for marketing in Japan.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20126/30/2012Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board James C.Fox 63 2/27/2009 2/27/2009
Chief Executive Officer, Managing Director, Executive Director Peter C.Cook 67 12/9/2005 12/9/2005
Chief Financial Officer, Company Secretary Damian T.Lismore 8/26/2005 8/26/2005
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Biota Holdings Ltd.
Biota Scientific Management Pty Ltd.

General Information
Number of Employees: 34 (As of 6/30/2005)
Outstanding Shares: 181,799,213 (As of 6/30/2012)
Shareholders: 11,813
Stock Exchange: ASX
Fax Number: +61 399153702


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023